Potential cardiotoxicity induced by Euodiae Fructus: In vivo and in vitro experiments and untargeted metabolomics research

Background: Euodiae Fructus, a well-known herbal medicine, is widely used in Asia and has also gained in popularity in Western countries over the last decades. It has known side effects, which have been observed in clinical settings, but few studies have reported on its cardiotoxicity.Methods: In th...

Full description

Saved in:
Bibliographic Details
Main Authors: Dan Zhang (Author), Jintao Lü (Author), Zhixin Ren (Author), Xiaomeng Zhang (Author), Huanzhang Wu (Author), Rina Sa (Author), Xiaofang Wang (Author), Yu Wang (Author), Zhijian Lin (Author), Bing Zhang (Author)
Format: Book
Published: Frontiers Media S.A., 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3b0e6d7f2f6d4851b4f6eba7df6b778f
042 |a dc 
100 1 0 |a Dan Zhang  |e author 
700 1 0 |a Jintao Lü  |e author 
700 1 0 |a Zhixin Ren  |e author 
700 1 0 |a Xiaomeng Zhang  |e author 
700 1 0 |a Xiaomeng Zhang  |e author 
700 1 0 |a Huanzhang Wu  |e author 
700 1 0 |a Rina Sa  |e author 
700 1 0 |a Rina Sa  |e author 
700 1 0 |a Xiaofang Wang  |e author 
700 1 0 |a Yu Wang  |e author 
700 1 0 |a Yu Wang  |e author 
700 1 0 |a Zhijian Lin  |e author 
700 1 0 |a Zhijian Lin  |e author 
700 1 0 |a Bing Zhang  |e author 
700 1 0 |a Bing Zhang  |e author 
245 0 0 |a Potential cardiotoxicity induced by Euodiae Fructus: In vivo and in vitro experiments and untargeted metabolomics research 
260 |b Frontiers Media S.A.,   |c 2022-10-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2022.1028046 
520 |a Background: Euodiae Fructus, a well-known herbal medicine, is widely used in Asia and has also gained in popularity in Western countries over the last decades. It has known side effects, which have been observed in clinical settings, but few studies have reported on its cardiotoxicity.Methods: In the present study, experiments using techniques of untargeted metabolomics clarify the hazardous effects of Euodiae Fructus on cardiac function and metabolism in rats in situations of overdosage and unsuitable syndrome differentiation. In vitro assays are conducted to observe the toxic effects of evodiamine and rutaecarpine, two main chemical constituents of Euodiae Fructus, in H9c2 and neonatal rat cardiomyocytes (NRCMs), with their signaling mechanisms analyzed accordingly.Results: The cardiac cytotoxicity of evodiamine and rutaecarpine in in vivo experiments is associated with remarkable alterations in lactate dehydrogenase, creatine kinase, and mitochondrial membrane potential; also with increased intensity of calcium fluorescence, decreased protein expression of the cGMP-PKG pathway in H9c2 cells, and frequency of spontaneous beat in NRCMs. Additionally, the results in rats with Yin deficiency receiving a high-dosage of Euodiae Fructus suggest obvious cardiac physiological dysfunction, abnormal electrocardiogram, pathological injuries, and decreased expression of PKG protein. At the level of endogenous metabolites, the cardiac side effects of overdose and irrational usage of Euodiae Fructus relate to 34 differential metabolites and 10 metabolic pathways involving among others, the purine metabolism, the glycerophospholipid metabolism, the glycerolipid metabolism, and the sphingolipid metabolism.Conclusion: These findings shed new light on the cardiotoxicity induced by Euodiae Fructus, which might be associated with overdose and unsuitable syndrome differentiation, that comes from modulating the cGMP-PKG pathway and disturbing the metabolic pathways of purine, lipid, and amino acid. Continuing research is needed to ensure pharmacovigilance for the safe administration of Chinese herbs in the future. 
546 |a EN 
690 |a Euodiae Fructus 
690 |a cardiotoxicity 
690 |a H9c2 
690 |a neonatal rat cardiomyocytes 
690 |a molecular mechanism 
690 |a untargeted metabolomics 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 13 (2022) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2022.1028046/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/3b0e6d7f2f6d4851b4f6eba7df6b778f  |z Connect to this object online.